Scientific governance and the process for exposure scenario development in REACH

C. Money,J. V. Hemmen,T. Vermeire

DOI: https://doi.org/10.1038/sj.jes.7500564

2007-05-09

Abstract:

What problem does this paper attempt to address?

Towards benchmarking actor- and agent-based programming languages

R. C. Cardoso,M. R. Zatelli,J. Hübner,Rafael Heitor Bordini

DOI: https://doi.org/10.1145/2541329.2541339

2013-10-27

Abstract:Over the past few years there have been several advances in distributed systems, and more recently multi-core processors. Consequently, a natural need for concurrent and parallel programming languages arises. In this paper, we compare some aspects of two concurrency models, Actors and Agents, using benchmarks to evaluate: (i) the communication performance on a concurrency-heavy scenario; (ii) the performance in a scenario with the presence of bottleneck and synchronization problems; and (iii) the reactivity and fairness of the models. We chose Jason, 2APL, and GOAL as the agent-oriented programming languages and Erlang, Akka, and ActorFoundry as the actor-oriented programming languages. Overall, Erlang displayed the best performance of all languages used in this comparison, followed by ActorFoundry, Akka, Jason, 2APL, and GOAL, in this particular order.
A framework for chemical safety assessment incorporating new approach methodologies within REACH

Nicholas Ball,Remi Bars,Philip A. Botham,Andreea Cuciureanu,Mark T. D. Cronin,John E. Doe,Tatsiana Dudzina,Timothy W. Gant,Marcel Leist,Bennard van Ravenzwaay

DOI: https://doi.org/10.1007/s00204-021-03215-9

2022-02-01

Archives of Toxicology

Abstract:Abstract The long-term investment in new approach methodologies (NAMs) within the EU and other parts of the world is beginning to result in an emerging consensus of how to use information from in silico, in vitro and targeted in vivo sources to assess the safety of chemicals. However, this methodology is being adopted very slowly for regulatory purposes. Here, we have developed a framework incorporating in silico , in vitro and in vivo methods designed to meet the requirements of REACH in which both hazard and exposure can be assessed using a tiered approach. The outputs from each tier are classification categories, safe doses, and risk assessments, and progress through the tiers depends on the output from previous tiers. We have exemplified the use of the framework with three examples. The outputs were the same or more conservative than parallel assessments based on conventional studies. The framework allows a transparent and phased introduction of NAMs in chemical safety assessment and enables science-based safety decisions which provide the same level of public health protection using fewer animals, taking less time, and using less financial and expert resource. Furthermore, it would also allow new methods to be incorporated as they develop through continuous selective evolution rather than periodic revolution.

toxicology
Towards a more effective reach legislation in protecting human health more effective reach in protecting human health

Lode Godderis,Evi De Ryck,Willy Baeyens,Lieve Geerts,Griet Jacobs,Phillippe Maesen,Birgit Mertens,Guy Schroyen,Frank Van Belleghem,Jeroen Vanoirbeek,Nicolas Van Larebeke

DOI: https://doi.org/10.1093/toxsci/kfae025

2024-02-28

Toxicological Sciences

Abstract:Abstract There is growing evidence indicating the substantial contribution of man-made products to an increase in the risk of diseases of civilization. In this article, the Belgian Scientific Registration, Evaluation, Authorization and restriction of CHemicals (REACH) Committee gives a critical view on the working of REACH. The current regulatory framework needs to further evolve taking into account data generated using modern science and technology. There is a need for improved assessment process not only before but also after entering the market. Objectivity, transparency, and the follow-up after market access can be optimized. Additionally, no guidance documents exist for regulation of mixture effects. Further, the lengthiness before regulatory action is a big concern. Decision making often takes several years leading to uncertainties for both producers and end users. A first proposed improvement is the implementation of independent toxicity testing, to assure objectivity, transparency, and check and improve compliance. A “no data, no market” principle could prevent access of hazardous chemicals to the market. Additionally, the introduction of novel testing could improve information on endpoints such as endocrine disrupting abilities, neurotoxicity, and immunotoxicity. An adapted regulatory framework that integrates data from different sources and comparing the outputs with estimates of exposure is required. Fast toxicology battery testing and toxicokinetic testing could improve speed of decision making. Hereby, several improvements have been proposed that could improve the current REACH legislation.

toxicology
[Bacterostatic effect of various oral hypoglycemizing preparations].

F. Bonetti

1957-08-01

Abstract:
Innovative analytical methodologies for characterizing chemical exposure with a view to next-generation risk assessment

Žiga Tkalec,Jean-Philippe Antignac,Nicole Bandow,Frederic M Béen,Lidia Belova,Jos Bessems,Bruno Le Bizec,Werner Brack,German Cano-Sancho,Jade Chaker,Adrian Covaci,Nicolas Creusot,Arthur David,Laurent Debrauwer,Gaud Dervilly,Radu Corneliu Duca,Valérie Fessard,Joan O Grimalt,Thierry Guerin,Baninia Habchi,Helge Hecht,Juliane Hollender,Emilien L Jamin,Jana Klánová,Tina Kosjek,Martin Krauss,Marja Lamoree,Gwenaelle Lavison-Bompard,Jeroen Meijer,Ruth Moeller,Hans Mol,Sophie Mompelat,An Van Nieuwenhuyse,Herbert Oberacher,Julien Parinet,Christof Van Poucke,Robert Roškar,Anne Togola,Jurij Trontelj,Elliott J Price,Frederic M. Béen,Joan O. Grimalt,Emilien L. Jamin,Elliott J. Price

DOI: https://doi.org/10.1016/j.envint.2024.108585

IF: 11.8

2024-04-01

Environment International

Abstract:The chemical burden on the environment and human population is increasing. Consequently, regulatory risk assessment must keep pace to manage, reduce, and prevent adverse impacts on human and environmental health associated with hazardous chemicals. Surveillance of chemicals of known, emerging, or potential future concern, entering the environment-food-human continuum is needed to document the reality of risks posed by chemicals on ecosystem and human health from a one health perspective, feed into early warning systems and support public policies for exposure mitigation provisions and safe and sustainable by design strategies. The use of less-conventional sampling strategies and integration of full-scan, high-resolution mass spectrometry and effect-directed analysis in environmental and human monitoring programmes have the potential to enhance the screening and identification of a wider range of chemicals of known, emerging or potential future concern. Here, we outline the key needs and recommendations identified within the European Partnership for Assessment of Risks from Chemicals (PARC) project for leveraging these innovative methodologies to support the development of next-generation chemical risk assessment.

environmental sciences
'Stoffenmanager', a web-based control banding tool using an exposure process model

Hans Marquart,Henri Heussen,Maaike Le Feber,Dook Noy,Erik Tielemans,Jody Schinkel,John West,Doeke Van Der Schaaf

DOI: https://doi.org/10.1093/annhyg/men032

Abstract:In the scope of a Dutch programme to reinforce the working conditions policy on hazardous substances, an internet-based tool was developed to help small- and medium-sized companies to handle hazardous substances with more care. The heart of this tool, called the Stoffenmanager, is a risk banding scheme. It combines a hazard banding scheme similar to that of COSHH Essentials and an exposure banding scheme based on an exposure model originally presented by Cherrie et al. (1996) and further developed by Cherrie and Schneider (1999). The exposure model has been modified to allow non-expert users to understand and use the model. Exposure scores are calculated based on categorization of determinants of emission, transmission and immission. These exposure scores are assigned to exposure bands. The comparison of exposure bands and hazard bands leads to a risk band or priority band. Following the evaluation of the priority of tasks done with products, generic exposure control measures can be evaluated for their possibility to lower the risks. Relevant control measures can be put into an action plan and into workplace instruction cards. The tool has several other functionalities regarding registration and storage of products. The exposure model in the Stoffenmanager leads to exposure scores. These have been compared with measured exposure levels. The exposure scores correlated well with measured exposure levels. The development of the Stoffenmanager has facilitated a whole range of further developments of useful tools for small- and medium-sized enterprises.
Exploring REACH as a potential data source for characterizing ecotoxicity in life cycle assessment

Nienke Müller,Dick de Zwart,Michael Hauschild,Gaël Kijko,Peter Fantke

DOI: https://doi.org/10.1002/etc.3542

2016-08-02

Environmental Toxicology and Chemistry

Abstract:Toxicity models in life cycle impact assessment (LCIA) currently only characterize a small fraction of marketed substances, mostly because of limitations in the underlying ecotoxicity data. One approach to improve the current data situation in LCIA is to identify new data sources, such as the European Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH) database. The present study explored REACH as a potential data source for LCIA based on matching reported ecotoxicity data for substances that are currently also included in the United Nations Environment Programme/Society for Environmental Toxicology and Chemistry (UNEP/SETAC) scientific consensus model USEtox for characterizing toxicity impacts. Data are evaluated with respect to number of data points, reported reliability, and test duration, and are compared with data listed in USEtox at the level of hazardous concentration for 50% of the covered species per substance. The results emphasize differences between data available via REACH and in USEtox. The comparison of ecotoxicity data from REACH and USEtox shows potential for using REACH ecotoxicity data in LCIA toxicity characterization, but also highlights issues related to compliance of submitted data with REACH requirements as well as different assumptions underlying regulatory risk assessment under REACH versus data needed for LCIA. Thus, further research is required to address data quality, pre-processing, and applicability, before considering data submitted under REACH as a data source for use in LCIA, and also to explore additionally available data sources, published studies, and reports. Environ Toxicol Chem 2017;36:492-500. © 2016 SETAC.

environmental sciences,toxicology
Infant Growth During the First Year of Life and Subsequent Hospitalization to 8 Years of Age

L. Hui,C. Schooling,M. Wong,L. Ho,T. Lam,G. Leung

DOI: https://doi.org/10.1097/EDE.0b013e3181cd709e

2010-05-01

Epidemiology

Abstract:Background: There is accumulating evidence that rapid infant growth is associated with subsequent metabolic risk, but less investigation of potential benefits. We tested the life history trade-off hypothesis that rapid infant growth is associated with lower risk of serious childhood morbidity (in particular, infection) proxied by hospital admission. Methods: We studied term births (n = 7833, 94% follow-up) from a Chinese birth cohort, “Children of 1997,” comprising 88% of births in Hong Kong in April and May 1997. We used multivariable negative binomial regression to examine the association of growth trajectory (5 categories) from birth to 12 months with subsequent hospital admissions until the child's 8th birthday. Potential confounders included sex, gestational age, parental education, type of birth hospital, infant feeding, and the presence of congenital disease. Results: Infants with the slowest growth trajectory (smallest birth weight and slowest weight gain) were more likely to be hospitalized between 1 and 8 years of age—particularly for noninfectious illnesses. Infants in the 4 faster growth trajectories differed little in their risk of hospitalization. Adjusted incident rate ratios of hospitalization for infectious diseases were 0.93 (95% confidence interval = 0.81–1.06), 0.97 (0.85–1.12), 0.91 (0.78–1.06), and 0.92 (0.79–1.08) for the 4 faster growth trajectories compared with the slowest. Results were similar when growth was assessed as change in weight-for-age z-score. Conclusion: Fast infant growth does not protect against serious infectious morbidity, but low birth weight infants born with slow growth are more vulnerable to serious morbidity, either as a consequence of poor growth or as a parallel marker of underlying health state. Whether maximum growth rates are ideal should be considered, as should the effects of infant over-nutrition.
Unlocking the potential of data harmonization and FAIRness in chemical risk assessment: lessons from practice and insights for policy development

Freudenthal, Oona

DOI: https://doi.org/10.1186/s12302-024-01022-4

2024-11-09

Environmental Sciences Europe

Abstract:Persistent and toxic chemicals remain a significant pollution concern, underscored by the European Union's Zero Pollution Action Plan. Daily exposure to complex chemical mixtures starts early and continues throughout life, for instance for consumer products such as toys, plasticware, furniture, and synthetic fibres. EU-funded research projects like COPHES/DEMOCOPHES, HBM4EU, and PARC have documented population exposure to these substances. The outcomes of such research initiatives have contributed to highlighting the adverse health impacts of Substances of Concern (SoCs), leading to several regulatory actions within the EU. SoCs include hazardous chemicals such as carcinogens, mutagens, endocrine disruptors, and "persistent, bioaccumulative, and mobile" (PBM) chemicals. The digital transformation in chemicals management has resulted in policies that mandate electronic submissions of chemical risk assessment-relevant data, and the creation of industry-specific databases like the Substances of Concern in Products (SCIP) database, established by the European Chemicals Agency (ECHA) under the revised Waste Framework Directive (WstFD). These databases describe SoCs and their link with products, offering a comprehensive view of chemical quantities, emission sources, exposure pathways, and other relevant data, contingent on robust data governance. Effective chemical risk assessment requires characterizing hazards, exposure sources and levels, and drawing conclusions concluding on potential risks, supported by a well-defined problem formulation and monitoring. This includes setting objectives and defining the scope of the risk assessment and decision-making, particularly regarding early warning signal detection for the purpose of public health protection. Successful risk assessment hinges on access to robust, traceable, accessible, and interoperable data across scientific disciplines and regulatory frameworks. This paper discusses the challenges of aggregating human health risk assessment-relevant chemical information from multiple sources, especially from the perspective of data fusion and reuse. It presents findings from a research project focused on utilizing chemicals datasets from various governmental and scientific sources. The study highlights the need for improved data presentation and availability to enhance usability for all stakeholders. Recommendations are made for the EU Commission, ECHA, industry, and academia to support harmonized data practices, increased transparency, and the development of sustainable chemical applications fostering safer market introductions. These recommendations can also be useful to other data providers that care about the reusability of the data they publish or manage.

environmental sciences
A European nano-registry as a reliable database for quantitative risk assessment of nanomaterials? A comparison of national approaches

Anna Pavlicek,Florian Part,Gloria Rose,Antonia Praetorius,Martin Miernicki,André Gazsó,Marion Huber-Humer

DOI: https://doi.org/10.1016/j.impact.2020.100276

IF: 6.038

NanoImpact

Abstract:Despite the fact that nanomaterials have been in use for decades and chemicals legislation is largely harmonised within the EU, quantitative and safety-relevant information on nanomaterials is still scarce. In particular, information about production volumes, their unique physicochemical properties (size, specific surface area, etc.) and nanomaterial exposure, which may lead to adverse effects on human health and the environment, is still lacking. While the latest amendments of the REACH Annexes have led to certain improvements, a harmonised EU-wide nano-registry would provide additional quantitative data for risk assessment but is not foreseeable for the near future. Since the European Commission, the European Parliament and some member states take contrasting approaches to the regulation of nanomaterials, France, Belgium, Denmark, Sweden and Norway (as a country of the European Economic Area), launched national mandatory reporting systems to collect quantitative information, thus fostering early risk assessment of nanomaterials. In this study, we compare national registries - based on a literature review and expert interviews - and show differences between the regulations under the respective national laws and REACH regulation. These include, for instance, thresholds for notification and level of detail on the specification of the nanomaterial, mixture and/or product, the definition of exceptions for the requirement to register and the timing of registration. As this heterogenous regulatory framework hinders comparability and potentially creates trade barriers, we argue that a harmonised EU-wide nano-registry would substantially improve the current situation by promoting the safe and sustainable handling of nanomaterials, increasing transparency and trust, and consequently nurturing innovation. Such an EU-wide nano-registry should both cover nanomaterials as substances or mixtures, such as in REACH registration, and the semi-/finished products they will be used in, since the exposure, and thus the hazardous potential of released nanomaterials during their life cycle, depends largely on the scope of application.
The role of European chemical manufacturing companies in promoting effective communication of conditions of safe use by workers

Jan Urbanus,Evelyn Tjoe Nij,Cornelia Tietz

DOI: https://doi.org/10.1093/annweh/wxae042

2024-07-08

Abstract:In 2006, the revised chemicals management legislation mandated that manufacturers of hazardous chemical substances conduct risk assessments for the entire substance life cycle. Additionally, they must communicate use-specific safe handling advice (exposure scenarios) to their customer, as annex to the Safety Data Sheet (SDS). Despite significant efforts to develop workable solutions for chemical mixtures, this goal has not yet been fully achieved. Therefore, a Cefic research project (LRI B23) was commissioned on how to ensure meaningful health risk communication for workers across supply chains. The research project determined that risk-based safe use advice generated by manufacturers, often does not reach the intended end-user and was seen as not tailored to specific user needs. Recipients of the advice are also not prepared to act based on information developed by suppliers. From an industry perspective, the complexity of supply chains and substance life cycles are considered major barriers for effective safe use communication. Exposure scenarios for substance use in industrial work environments are often perceived as adding little value compared to existing safe use arrangements required by other health, safety, and environmental legislation applicable to employers and duty-holders. To attain meaningful use-specific safe handling advice for workers, including those at non-industrial premises who may benefit most from such advice, knowledge transfer and close collaboration between manufacturers and formulators remain key elements, supported by enhanced regulatory appreciation.
Are Hazard Assessment Methods in the Assessment of Chemical Alternatives Suitable for REACH?

Rachel L. London,Juliane Glüge,Martin Scheringer

DOI: https://doi.org/10.1021/acs.est.4c03979

IF: 11.4

2024-10-10

Environmental Science & Technology

Abstract:The assessment of chemical alternatives for hazardous substances is an important prerequisite for avoiding regrettable substitution, and several methods have been developed in the past to perform such a hazard assessment for chemical alternatives. We investigate here whether GreenScreen, Cradle to Cradle, multiple-criteria decision analysis (MCDA), the Pollution Prevention Options Analysis System, the U.S. EPA Safer Choice Standard and Criteria, and the GHS column model 2020 from IFA use similar...

environmental sciences,engineering, environmental
Development of risk-based nanomaterial groups for occupational exposure control

E. D. Kuempel,V. Castranova,C. L. Geraci,P. A. Schulte

DOI: https://doi.org/10.1007/s11051-012-1029-8

IF: 2.533

2012-08-07

Journal of Nanoparticle Research

Abstract:Given the almost limitless variety of nanomaterials, it will be virtually impossible to assess the possible occupational health hazard of each nanomaterial individually. The development of science-based hazard and risk categories for nanomaterials is needed for decision-making about exposure control practices in the workplace. A possible strategy would be to select representative (benchmark) materials from various mode of action (MOA) classes, evaluate the hazard and develop risk estimates, and then apply a systematic comparison of new nanomaterials with the benchmark materials in the same MOA class. Poorly soluble particles are used here as an example to illustrate quantitative risk assessment methods for possible benchmark particles and occupational exposure control groups, given mode of action and relative toxicity. Linking such benchmark particles to specific exposure control bands would facilitate the translation of health hazard and quantitative risk information to the development of effective exposure control practices in the workplace. A key challenge is obtaining sufficient dose–response data, based on standard testing, to systematically evaluate the nanomaterials’ physical–chemical factors influencing their biological activity. Categorization processes involve both science-based analyses and default assumptions in the absence of substance-specific information. Utilizing data and information from related materials may facilitate initial determinations of exposure control systems for nanomaterials.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Can “Hazard-Cost-Effectiveness Analysis” improve the risk management of chemicals under REACH?

Jean-Marc Brignon,Jean-Christophe Vergnaud,Sandrine Andres,Enrico Mombelli,Tsarafara Rambolarimanana

DOI: https://doi.org/10.1016/j.yrtph.2024.105561

IF: 3.598

2024-02-01

Regulatory Toxicology and Pharmacology

Abstract:Cost-Effectiveness Analysis (CEA) is a decision-making framework to prioritize policy decisions for chemicals. Differences in hazard profiles among chemicals are not integrated in CEA under the EU REACH Regulation, which could limit its relevance. Another concern is that two different economic decision support methods (CEA for chemicals considered as PBTs or vPvBs from a regulatory perspective and Cost Benefit Analysis (CBA) for others) are used under REACH. To address this situation, we define "Hazard" CEA by integrating a hazard score, based on persistence, bioaccumulation and (eco)toxicity, in the effect indicator of CEA. We test different designs and parameterizations of Hazard-CEA on a set of past socio-economic assessments under REACH for PBT and non-PBT chemicals. Weighing and thresholds in hazard scores do not have a significant impact on the outcome of Hazard-CEA but the design of the hazard scoring method does. We suggest using an integrated and unweighted scoring method with a multiplicative formulation based on the notion of risk. Hazard-CEA could be used for both PBT and non-PBT chemicals, to use a single method in REACH and therefore improve consistency in policy decisions. Our work also suggests that using Hazard-CEA could help make decision easier.

pharmacology & pharmacy,toxicology,medicine, legal
New small polypeptides associated with DNA-dependent RNA polymerase of Escherichia coli after infection with bacteriophage T4.

A. Stevens

DOI: https://doi.org/10.1073/PNAS.69.3.603

1972-03-01

Abstract:Four new small polypeptides are associated with DNA-dependent RNA polymerase from E. coli after infection with T4 phage. The new polypeptides are easily detected in RNA polymerase from E. coli cells labeled with amino acids after phage infection. Their molecular weights range from 10,000 to 22,000, as detected by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. All four polypeptides are found after infection with either wild-type T4 phage or T4 early amber mutants in genes 44, 42, 47, and 46. None of the polypeptides is labeled significantly before 5 min after infection at 30 degrees . When two maturation-defective amber mutants in gene 55 of T4 phage are used for infection, a polypeptide with a molecular weight of 22,000 is absent. When a maturation-defective amber mutant in gene 33 of T4 phage is used, another small protein is absent.
Accessible methods and tools to estimate chemical exposure in humans to support risk assessment: A systematic scoping review

Maria E Kalyva,Gunn E Vist,Michael Guy Diemar,Graciela López-Soop,T J Bozada,Thomas Luechtefeld,Erwin L Roggen,Hubert Dirven,Mathieu Vinken,Trine Husøy

DOI: https://doi.org/10.1016/j.envpol.2024.124109

2024-07-01

Abstract:Exposure assessment is a crucial component of environmental health research, providing essential information on the potential risks associated with various chemicals. A systematic scoping review was conducted to acquire an overview of accessible human exposure assessment methods and computational tools to support and ultimately improve risk assessment. The systematic scoping review was performed in Sysrev, a web platform that introduces machine learning techniques into the review process aiming for increased accuracy and efficiency. Included publications were restricted to a publication date after the year 2000, where exposure methods were properly described. Exposure assessments methods were found to be used for a broad range of environmental chemicals including pesticides, metals, persistent chemicals, volatile organic compounds, and other chemical classes. Our results show that after the year 2000, for all the types of exposure routes, probabilistic analysis, and computational methods to calculate human exposure have increased. Sixty-three mathematical models and toolboxes were identified that have been developed in Europe, North America, and globally. However, only twelve occur frequently and their usefulness were associated with exposure route, chemical classes and input parameters used to estimate exposure. The outcome of the combined associations can function as a basis and/or guide for decision making for the selection of most appropriate method and tool to be used for environmental chemical human exposure assessments in Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment (ONTOX) project and elsewhere. Finally, the choice of input parameters used in each mathematical model and toolbox shown by our analysis can contribute to the harmonization process of the exposure models and tools increasing the prospect for comparison between studies and consistency in the regulatory process in the future.
Selective detection of bacteria in urine with a long-range surface plasmon waveguide biosensor.

P. Béland,O. Krupin,P. Berini

DOI: https://doi.org/10.1364/BOE.6.002908

IF: 3.4

2015-08-01

Biomedical Optics Express

Abstract:Experimentation demonstrates long-range surface plasmon polariton waveguides as a useful biosensor to selectively detect gram negative or gram positive bacteria in human urine having a low concentration of constituents. The biosensor can detect bacteria at concentrations of 10(5) CFU/ml, the internationally recommended threshold for diagnostic of urinary tract infection. Using a negative control urine solution of bacterial concentration 1000☓ higher than the targeted bacteria, we obtain a ratio of 5.4 for the positive to negative signals.
Exposure based waiving: the application of the toxicological threshold of concern (TTC) to inhalation exposure for aerosol ingredients in consumer products

P Carthew,C Clapp,S Gutsell

DOI: https://doi.org/10.1016/j.fct.2009.02.024

Abstract:The inhalation toxicology studies available in the public domain have been reviewed to establish a database for inhalation toxicology and derive thresholds of toxicological concern (TTC) for effects in the respiratory tract and systemically for Cramer class 1 and 3 chemicals. These TTCs can be used as the basis for developing an exposure based waiving (EBW) approach to evaluating the potential for adverse effects from exposure to ingredients in aerosol products, used by consumers. The measurement of consumer exposure in simulated product use is key to the application of an exposure based waiving approach to evaluating potential consumer risk. The detailed exposure evaluation for aerosol ingredients with defined use scenarios, in conjunction with an evaluation of the potential structure activity relationship for toxicity and the TTCs for inhalation exposure could be used to waive undertaking inhalation toxicology studies under REACH. Not all classes of chemicals are suitable for such an approach, but for chemicals with a predictable low potential toxicity, and very low levels of exposure, this approach, could reduce the amount of inhalation toxicology studies required for the implementation of the European REACH legislation. Such an approach is consistent with the concept of developing 'intelligent testing strategies' for REACH.
Environmental risk assessment in the EU regulation of medicines for human use: an analysis of stakeholder perspectives on its current and future role

Jim F. Zinken,Anna M.G. Pasmooij,Antwan G.H. Ederveen,Jarno Hoekman,Lourens T. Bloem

DOI: https://doi.org/10.1016/j.drudis.2024.104213

IF: 8.369

2024-10-22

Drug Discovery Today

Abstract:An environmental risk assessment (ERA) is mandatory for all applications for marketing authorisation of medicines in the European Union (EU). We investigated stakeholder perspectives on the role of the ERA in EU regulation of medicines for human use. We discuss the current position of the ERA, including the conduct and assessment of the ERA, such as the required expertise, data, and studies, its applicability to generic drugs, and its use in regulatory decision-making. We also discuss future...

pharmacology & pharmacy

Scientific governance and the process for exposure scenario development in REACH

Towards benchmarking actor- and agent-based programming languages

A framework for chemical safety assessment incorporating new approach methodologies within REACH

Towards a more effective reach legislation in protecting human health more effective reach in protecting human health

[Bacterostatic effect of various oral hypoglycemizing preparations].

Innovative analytical methodologies for characterizing chemical exposure with a view to next-generation risk assessment

'Stoffenmanager', a web-based control banding tool using an exposure process model

Exploring REACH as a potential data source for characterizing ecotoxicity in life cycle assessment

Infant Growth During the First Year of Life and Subsequent Hospitalization to 8 Years of Age

Unlocking the potential of data harmonization and FAIRness in chemical risk assessment: lessons from practice and insights for policy development

A European nano-registry as a reliable database for quantitative risk assessment of nanomaterials? A comparison of national approaches

The role of European chemical manufacturing companies in promoting effective communication of conditions of safe use by workers

Are Hazard Assessment Methods in the Assessment of Chemical Alternatives Suitable for REACH?

Development of risk-based nanomaterial groups for occupational exposure control

Can “Hazard-Cost-Effectiveness Analysis” improve the risk management of chemicals under REACH?

New small polypeptides associated with DNA-dependent RNA polymerase of Escherichia coli after infection with bacteriophage T4.

Accessible methods and tools to estimate chemical exposure in humans to support risk assessment: A systematic scoping review

Selective detection of bacteria in urine with a long-range surface plasmon waveguide biosensor.

Exposure based waiving: the application of the toxicological threshold of concern (TTC) to inhalation exposure for aerosol ingredients in consumer products

Environmental risk assessment in the EU regulation of medicines for human use: an analysis of stakeholder perspectives on its current and future role